A Japanese pharmaceutical giant and Massachusetts biotechnology company recently announced changes to their respective 340B contract pharmacy restrictions. Tokyo-based Takeda [...] …
Category: Pharma Industry
News Alert
Stakeholders React to HELP Committee Chair Cassidy’s 340B Probe Findings, Reform Recommendations
340B hospitals, contract pharmacies, health center advocates and the drug industry offered mixed responses Thursday on the long-awaited findings and [...] …
While much of the focus in Washington, D.C. has been on confirmation hearings and budget matters, the 340B program continued [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
The drug industry is bracing for the Trump administration’s planned tariffs on pharmaceutical products and ingredients, warning of supply chain [...] …
The U.S. Department of Health and Human Services (HHS) is continuing its pushback against drugmaker attempts to unilaterally convert upfront [...] …
An influential drug industry trade group on Friday sued Utah over its 340B contract pharmacy access law, marking the third [...] …
Hospital and health center leaders are pushing back against President Donald Trump’s (R) new executive order, criticizing its controversial 340B [...] …
Merck is lifting its 340B contract pharmacy restrictions in three more states that have recently enacted contract pharmacy access laws—while [...] …
News Alert
Trump Revives Controversial 340B Rule for Insulin, EpiPens in Sweeping Health Care Executive Order
President Donald Trump (R) last night issued a wide-ranging health care executive order that revives a controversial 340B policy from [...] …